Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Cancer Therapy: Preclinical

Detection of Human Papillomavirus (HPV) 16-Specific CD4+ T-cell Immunity in Patients with Persistent HPV16-Induced Vulvar Intraepithelial Neoplasia in Relation to Clinical Impact of Imiquimod Treatment

Mariëtte I.E. van Poelgeest, Manon van Seters, Marc van Beurden, Kitty M.C. Kwappenberg, Claudia Heijmans-Antonissen, Jan W. Drijfhout, Cornelis J.M. Melief, Gemma G. Kenter, Theo J.M. Helmerhorst, Rienk Offringa and Sjoerd H. van der Burg
Mariëtte I.E. van Poelgeest
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manon van Seters
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc van Beurden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kitty M.C. Kwappenberg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudia Heijmans-Antonissen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan W. Drijfhout
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cornelis J.M. Melief
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gemma G. Kenter
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Theo J.M. Helmerhorst
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rienk Offringa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sjoerd H. van der Burg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1078-0432.CCR-05-0616 Published July 2005
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: July 2005 to April 2021

AbstractFull-text HTMLPDF
Total260668902649

Cited By

Article Information

Volume 11, Issue 14, pp. 5273-5280

DOI 
https://doi.org/10.1158/1078-0432.CCR-05-0616
PubMed 
16033846

Published By 
American Association for Cancer Research
Print ISSN 
1078-0432
Online ISSN 
1557-3265
History 
  • Accepted April 29, 2005
  • Received March 21, 2005
  • Revision received April 27, 2005
  • Published first July 20, 2005.

Copyright & Usage 
American Association for Cancer Research

Author Information

  1. Mariëtte I.E. van Poelgeest1,
  2. Manon van Seters3,6,
  3. Marc van Beurden5,6,
  4. Kitty M.C. Kwappenberg2,
  5. Claudia Heijmans-Antonissen4,
  6. Jan W. Drijfhout2,
  7. Cornelis J.M. Melief2,
  8. Gemma G. Kenter1,
  9. Theo J.M. Helmerhorst3,
  10. Rienk Offringa2 and
  11. Sjoerd H. van der Burg2
  1. Authors' Affiliations: Departments of 1Gynecology and 2Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands; Departments of 3Gynecology and 4Anesthesiology, Erasmus University Medical Center, Rotterdam, The Netherlands; 5Department of Gynecology, The Netherlands Cancer Institute and 6Academic Medical Center, Amsterdam, The Netherlands
  1. Requests for reprints:
    Sjoerd H. van der Burg, Department of Immunohematology and Blood Transfusion, Building 1, E3-Q, Leiden University Medical Center, PO box 9600, 2300 RC Leiden, The Netherlands. Phone: 31-71-5266849; Fax: 31-71-5216751; E-mail: shvdburg{at}lumc.nl.
View Full Text
PreviousNext
Back to top
Clinical Cancer Research: 11 (14)
July 2005
Volume 11, Issue 14
  • Table of Contents
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Clinical Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Detection of Human Papillomavirus (HPV) 16-Specific CD4+ T-cell Immunity in Patients with Persistent HPV16-Induced Vulvar Intraepithelial Neoplasia in Relation to Clinical Impact of Imiquimod Treatment
(Your Name) has forwarded a page to you from Clinical Cancer Research
(Your Name) thought you would be interested in this article in Clinical Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Detection of Human Papillomavirus (HPV) 16-Specific CD4+ T-cell Immunity in Patients with Persistent HPV16-Induced Vulvar Intraepithelial Neoplasia in Relation to Clinical Impact of Imiquimod Treatment
Mariëtte I.E. van Poelgeest, Manon van Seters, Marc van Beurden, Kitty M.C. Kwappenberg, Claudia Heijmans-Antonissen, Jan W. Drijfhout, Cornelis J.M. Melief, Gemma G. Kenter, Theo J.M. Helmerhorst, Rienk Offringa and Sjoerd H. van der Burg
Clin Cancer Res July 15 2005 (11) (14) 5273-5280; DOI: 10.1158/1078-0432.CCR-05-0616

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Detection of Human Papillomavirus (HPV) 16-Specific CD4+ T-cell Immunity in Patients with Persistent HPV16-Induced Vulvar Intraepithelial Neoplasia in Relation to Clinical Impact of Imiquimod Treatment
Mariëtte I.E. van Poelgeest, Manon van Seters, Marc van Beurden, Kitty M.C. Kwappenberg, Claudia Heijmans-Antonissen, Jan W. Drijfhout, Cornelis J.M. Melief, Gemma G. Kenter, Theo J.M. Helmerhorst, Rienk Offringa and Sjoerd H. van der Burg
Clin Cancer Res July 15 2005 (11) (14) 5273-5280; DOI: 10.1158/1078-0432.CCR-05-0616
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Targeting HER2 with Osimertinib in NSCLC
  • Combined VEGF/EGFR Inhibition
  • Radiotherapy with IDO1/PD-1 Blockade Treats Advanced GBM
Show more Cancer Therapy: Preclinical
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement